<?xml version='1.0' encoding='UTF-8' standalone='yes'?>
<rss version="2.0">
  <channel>
    <title>Reviews in the Neurosciences</title>
    <link>www.degruyter.com</link>
    <description/>
    <item>
      <title>Frontmatter</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-frontmatter6/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-frontmatter6/html</guid>
    </item>
    <item>
      <title>An update to pain management after spinal cord injury: from pharmacology to circRNAs</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0089/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0089/html</guid>
    </item>
    <item>
      <title>Current advances in stem cell therapy in the treatment of multiple sclerosis</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0102/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0102/html</guid>
    </item>
    <item>
      <title>Targeting NMDA receptor signaling for therapeutic intervention in brain disorders</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0096/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0096/html</guid>
    </item>
    <item>
      <title>A review of the application of three-dimensional convolutional neural networks for the diagnosis of Alzheimer’s disease using neuroimaging</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0122/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2022-0122/html</guid>
    </item>
    <item>
      <title>A systematic review of the effects of transcranial photobiomodulation on brain activity in humans</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0003/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0003/html</guid>
    </item>
    <item>
      <title>Microbiota–gut–brain axis and related therapeutics in Alzheimer’s disease: prospects for multitherapy and inflammation control</title>
      <link>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0006/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0006/html</guid>
    </item>
  </channel>
</rss>
